is ozempic glp-1 Another Weight-Loss Trial Win for Weekly Drug Is GLP-1 the Same as

[30] [31] Patients with multiple risk factors for osteoporosis should be identified early in treatment for appropriate monitoring and preventive strategies

In a long-term cardio-renal outcome trial with empagliflozin, in patients with chronic kidney disease, the occurrence of lower limb amputations was reported with event rates of 2.9, and 4.3 events per 1,000 patient-years in the placebo, and empagliflozin 10 mg treatment arms, respectively

Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers

Heymsfield et al

Molecular Basis of Disease